Patrick Arbuthnot

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

University of the Witwatersrand

University of the Witwatersrand (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of the Witwatersrand

South Africa

Lecturer/Senior Lecturer/Reader/Personal Professor

INSERM

France

Postdoctoral fellow

Education History

University of the Witwatersrand

South Africa

PHD

University of the Witwatersrand

South Africa

BSC

University of the Witwatersrand

South Africa

BSC

Publications

Ridhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, Keila Neves, Stefan Barth, Patrick Arbuthnot, Mohube Betty Maepa
AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy. Microorganisms 11 (12) (2023)
Dylan Kairuz, Nazia Samudh, Abdullah Ely, Patrick Arbuthnot, Kristie Bloom
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines. Pharmaceutics 15 (4) (2023)
Dylan Kairuz, Nazia Samudh, Abdullah Ely, Patrick Arbuthnot, Kristie Bloom
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines. Pharmaceutics 15 (4) (2023)
Ridhwaanah Jacobs, Makafui Dennis Dogbey, Njabulo Mnyandu, Keila Neves, Stefan Barth, Patrick Arbuthnot, Mohube Betty Maepa
AAV Immunotoxicity: Implications in Anti-HBV Gene Therapy. Microorganisms 11 (12) (2023)
Dylan Kairuz, Nazia Samudh, Abdullah Ely, Patrick Arbuthnot, Kristie Bloom
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines. Pharmaceutics 15 (4) (2023)
Dylan Kairuz, Nazia Samudh, Abdullah Ely, Patrick Arbuthnot, Kristie Bloom
Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines. Pharmaceutics 15 (4) (2023)
Mohube B Maepa, Abdullah Ely, Anna Kramvis, Kristie Bloom, Kubendran Naidoo, Omphile E Simani, Tongai G Maponga, Patrick Arbuthnot
Hepatitis B Virus Research in South Africa. Viruses 14 (9) (2022)
Tasneem Farhad, Keila Neves, Patrick Arbuthnot, Mohube Betty Maepa
Adenoviral Vectors: Potential as Anti-HBV Vaccines and Therapeutics. Genes 13 (11) (2022)
Ridhwaanah Jacobs, Prashika Singh, Tiffany Smith, Patrick Arbuthnot, Mohube Betty Maepa
Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases. Gene therapy (2022)
Shonisani Wendy Limani, Njabulo Mnyandu, Abdullah Ely, Reubina Wadee, Anna Kramvis, Patrick Arbuthnot, Mohube Betty Maepa
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors. Viruses 13 (11) (2021)
Laura Mosti, Lukas M Langner, Kay O Chmielewski, Patrick Arbuthnot, Jamal Alzubi, Toni Cathomen
Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells. Gene therapy 28 (9) (2021)
Tiffany Smith, Prashika Singh, Kay Ole Chmielewski, Kristie Bloom, Toni Cathomen, Patrick Arbuthnot, Abdullah Ely
Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric FokI Nuclease Domains. Viruses 13 (7) (2021)
Fiona van den Berg, Shonisani Wendy Limani, Njabulo Mnyandu, Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection. Viruses 12 (8) (2020)
Kristie Bloom, Haajira Kaldine, Toni Cathomen, Claudio Mussolino, Abdullah Ely, Patrick Arbuthnot
Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA. BMC infectious diseases 19 (1) (2019)
Kristie Bloom, Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Gene Therapy for Chronic HBV-Can We Eliminate cccDNA? Genes 9 (4) (2018)

Patrick Arbuthnot.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Patrick Arbuthnot